A detailed history of Heritage Family Offices, LLP transactions in Abb Vie Inc. stock. As of the latest transaction made, Heritage Family Offices, LLP holds 9,428 shares of ABBV stock, worth $1.69 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
9,428
Previous 8,881 6.16%
Holding current value
$1.69 Million
Previous $1.58 Billion 25.17%
% of portfolio
1.01%
Previous 0.79%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 10, 2025

BUY
$169.2 - $216.66 $92,552 - $118,513
547 Added 6.16%
9,428 $1.98 Billion
Q4 2024

Jan 14, 2025

SELL
$164.99 - $203.87 $3,464 - $4,281
-21 Reduced 0.24%
8,881 $1.58 Billion
Q3 2024

Oct 16, 2024

BUY
$163.84 - $199.33 $491 - $597
3 Added 0.03%
8,902 $1.76 Billion
Q2 2024

Aug 01, 2024

BUY
$154.79 - $180.76 $1.38 Million - $1.61 Million
8,899 New
8,899 $1.53 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Heritage Family Offices, LLP Portfolio

Follow Heritage Family Offices, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Family Offices, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Family Offices, LLP with notifications on news.